Guideline D: Accreditation of a Learning Activity Focusing on a Unique Product

Reference: Accreditation Process

To download a copy of the Guideline, click here.

You may scroll down the page or click on the link to go to one of the following topics:

1.    Definitions

1.1.    Product. A product is a drug, device, technology or service.
1.2.    Single or Unique Product. A Single or Unique Product may be:

1.2.1.    A product that is the only product in a new class of drug or device;
1.2.2.    A drug or device that is the only one of its class licensed for use in Canada;
1.2.3.    A device or technology that has unique capabilities from other similar devices or technologies available in Canada; or
1.2.4.    A product deemed eligible as a single or unique product by CCCEP.

1.3.    Continuing Pharmacy Education Learning Activity. A learning activity objectively providing in-depth, balanced information on a topic or subject matter pertinent to contemporary pharmacy practice such as:

1.3.1.    The properties and actions of drugs and dosage forms;
1.3.2.    The etiology, characteristics, therapeutics, and prevention of disease states;
1.3.3.    The pharmaceutical monitoring and management of patient therapy;
1.3.4.    Information unique to specialized types of pharmacy practice;
1.3.5.    The social, ethical, behavioural, legal, pharmacoeconomic, administrative, and managerial aspects of pharmacy practice and health care.

1.4.    Product Information Learning Activity. A learning activity focusing on information about a specific product, its applications or how to use the product.

[Top of Page]

2.    Scope and Application

2.1.    This guideline applies to any learning activity that involves a single or unique product.
2.2.    A Continuing Pharmacy Education Learning Activity is eligible for accreditation under the Standards and Guidelines for CCCEP accreditation.
2.3.    A Product Information Learning Activity is deemed equivalent to product promotion and is therefore not normally eligible for CCCEP accreditation. However, a learning activity on a single or unique product may be considered a continuing education learning activity, and therefore eligible to be considered for accreditation, if it meets the conditions outlined in this Guideline.

[Top of Page]

3.    Accreditation of Learning Activities with Information about a Single or Unique Product

3.1.    CCCEP believes it is important that pharmacy professionals are able to access continuing pharmacy education learning activities about treatments and procedures that involve unique products.
3.2.    A learning activity that contains information on a single or unique therapeutic product (i.e., related to the treatment or care of a patient) may be considered for accreditation provided every effort is made to minimize bias in the learning activity. This may be achieved by meeting the following conditions:

3.2.1.    The focus of the learning activity is on the health condition and the treatment or management of the condition;
3.2.2.    The information about the product, its use and results is presented in a comparative format with other products, their uses and results;
3.2.3.    The basis for the information on the product is the product research, and the following will be presented:

3.2.3.1.    The scope, validity, reliability and limitations of the product;
3.2.3.2.    The indications, contraindications and limitations of the use of the product; and
3.2.3.3.    The conditions which may impact the effectiveness or safety of the product;

3.2.4.    The generic names for all products are used in the learning activity; and
3.2.5.    The learning activity meets all other Standards and Guidelines for CCCEP accreditation.

3.3.    A learning activity that contains information on a single or unique non-therapeutic product (i.e., related to the management and operation of the pharmacy practice) may be considered for accreditation provided every effort is made to minimize bias in the learning activity. This may be achieved by the equivalent conditions as presented in section 3.2 where the focus is on the management and operation of the practice and the comparable products are other non-therapeutic products.

[Top of Page]

4.    Preferred Reference Documents

4.1.    The preferred reference documents are third party research studies on the product.
4.2.    Corporate and product materials of the manufacturer are not to be used for references.
4.3.    A reference to a product monograph will meet the reference requirements of Standard 4 (Adult Learning).

[Top of Page]

5.    Updates and Renewals

5.1.    The learning activity will be updated within 30 days of a similar or equivalent product being introduced or available on the market.
5.2.    When renewing, the provider will verify that the product remains a single or unique product and is expected to remain a single or unique product for the renewal period. At a minimum, the provider will conduct a literature search for new products or new evidence on the product and the effects of the product.

[Top of Page]